Omnicell OMCL
NASDAQ OMCL
$34.37 -0.45 (-1.29%)
At close: Sep 4, 2026 · 4:00 PM EDT

Omnicell (OMCL) Cash from Investing Activities (2010 - 2026)

Omnicell's (OMCL) quarterly Cash from Investing Activities came in at -$12.5 million in Q2 2026, up 21.3% year-over-year from -$10.3 million in Q2 2025, and up 21.02% quarter-over-quarter from -$15.9 million in Q1 2026.

Analysis

Omnicell (OMCL) Cash from Investing Activities (2010 - 2026) Analysis & Trends

Omnicell (OMCL) has reported Cash from Investing Activities for 17 consecutive years, with -$12.5 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Cash from Investing Activities rose 21.3% year-over-year to -$12.5 million in Q2 2026; TTM through Jun 2026 was -$57.1 million, a 2.5% increase from a year earlier, with the FY2025 full-year figure at -$60.4 million, down 14.34% from the prior year.
  • Cash from Investing Activities was -$12.5 million for Q2 2026 at Omnicell, up from -$15.9 million in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at -$6.8 million in Q2 2022 and troughed at -$18.7 million in Q1 2022.
  • A 5-year average of -$14.2 million and a median of -$14.2 million in 2023 frame the typical range for Cash from Investing Activities.
  • Across the five-year window, Cash from Investing Activities soared 91.81% in 2022 and tumbled 117.35% in 2023, its largest moves.
  • Over 5 years, Cash from Investing Activities stood at -$17.3 million in 2022, then increased by 28.29% to -$12.4 million in 2023, then fell by 9.67% to -$13.6 million in 2024, then decreased by 6.28% to -$14.4 million in 2025, then climbed by 13.1% to -$12.5 million in 2026.
  • The last three Cash from Investing Activities figures came in at -$12.5 million (Q2 2026), -$15.9 million (Q1 2026), and -$14.4 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Abbott Laboratories 187.42 Bn 182.47 Bn 7.27 Bn -673.00 Mn
2 Intuitive Surgical 129.78 Bn 124.69 Bn 1.96 Bn -26.60 Mn
3 Medtronic 120.53 Bn 112.33 Bn 6.34 Bn -1.62 Bn
4 Stryker 116.28 Bn 112.80 Bn 4.50 Bn -639.00 Mn
5 Boston Scientific 69.29 Bn 68.99 Bn 3.85 Bn -1.96 Bn
6 Edwards Lifesciences 51.83 Bn 47.68 Bn 1.35 Bn -193.20 Mn
7 Alcon 34.36 Bn 32.91 Bn 1.68 Bn -222.00 Mn
8 Dexcom 33.17 Bn 31.23 Bn 830.00 Mn 329.80 Mn
9 Resmed 32.94 Bn 31.47 Bn 861.22 Mn -383.65 Mn
10 Omnicell 1.57 Bn 1.28 Bn 152.94 Mn -12.53 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -12.53 Mn
Mar 31, 2026 -15.87 Mn
Dec 31, 2025 -14.42 Mn
Sep 30, 2025 -14.28 Mn
Jun 30, 2025 -15.92 Mn
Mar 31, 2025 -15.74 Mn
Dec 31, 2024 -13.57 Mn
Sep 30, 2024 -13.34 Mn
Jun 30, 2024 -13.55 Mn
Mar 31, 2024 -12.34 Mn
Dec 31, 2023 -12.37 Mn
Sep 30, 2023 -14.19 Mn
Jun 30, 2023 -14.82 Mn
Mar 31, 2023 -13.64 Mn
Dec 31, 2022 -17.25 Mn
Sep 30, 2022 -15.87 Mn
Jun 30, 2022 -6.82 Mn
Mar 31, 2022 -18.73 Mn
Dec 31, 2021 -192.39 Mn
Sep 30, 2021 -193.63 Mn